Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…

Heart in Diabetes (HiD)

C. Shufelt

High Value Care in Endocrinology

University of Louisville

M. Rawal

Vitamin D and its Supplementation: Where is the Evidence and Should …

UCSF School of Medicine

C. J. Rosen

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Weightloss in Menopause

Susan Brian

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Obesity and Heart Health: Weighing the Facts

The North American Thrombosis Forum (NATF)

K. D. Palmer Emrich

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Medical Treatment of Hypercortisolism With Relacorilant: Final Resul…

Heart in Diabetes (HiD)

R. Pivonello

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Type 2 Diabetes - Medical Management

Michigan Medicine

A. Rothberg

Anabolic Agents and Their Incorporation into Treatment Regimens

UCSF School of Medicine

A. Schafer

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

Wegovy 2024 Updates

Susan Brian

Vitamin D: New Insights and Controversies

Osteoporosis Foundation of New Mexico

J. Bilezikian

ACC 2024 Insights: A Plant-Based Diet

ACC 2024 Insights

N. Barnard